Share-Based Payments (Tables)
|
12 Months Ended |
Dec. 31, 2022 |
SHARE-BASED PAYMENTS |
|
Schedule of Share-Based Payment Expense |
| | | | | | | € millions | | 2022 | | 2021 | | 2020 | Cost of cloud | | 68 | | 59 | | 40 | Cost of software licenses and support | | 70 | | 70 | | 55 | Cost of services | | 281 | | 266 | | 175 | Research and development | | 625 | | 513 | | 296 | Sales and marketing | | 773 | | 655 | | 360 | General and administration | | 798 | | 1,230 | | 157 | Share-based payment expenses | | 2,614 | | 2,794 | | 1,084 | Thereof cash-settled share-based payments | | 355 | | 1,147 | | 893 | Thereof equity-settled share-based payments | | 2,258 | | 1,647 | | 191 |
|
Summary of Share Based Payment Liabilities As Part of Other Non-Financial Liabilities |
| | | | | | | € millions | | 2022 | | 2021 | | 2020 | Own | | 307 | | 200 | | 191 | Qualtrics Plan | | 1,164 | | 1,426 | | NA | Move (2022 Tranches) | | 768 | | NA | | NA | Others | | 19 | | 21 | | 0 | Total | | 2,258 | | 1,647 | | 191 |
|
Cash-Settled Plans |
|
SHARE-BASED PAYMENTS |
|
Summary of Fair Value and Parameters Used at Grant Date |
Fair Value and Parameters Used at Year End 2022 | | | | | | | €, unless otherwise stated | | LTI 2016 Plan | | LTI 2020 | | Move | | | (2019 Tranche) | | (2020-2022 | | (2019–2022 | | | | | Tranches) | | Tranches) | Weighted average fair value as at 12/31/2022 | | 67.81 | | 94.83 | | 94.78 | Information how fair value was measured at measurement date | | | | | | | Valuation model used | | Monte Carlo | | Monte Carlo | | Other1 | Share price | | 96.39 | | 96.39 | | 96.39 | Risk-free interest rate, depending on maturity (in %) | | 0.37 | | NA | | NA | Expected volatility (in %) | | 27 | | 24 to 31 | | NA | Expected dividend yield (in %) | | 2.03 | | NA | | 2.03 | Weighted average remaining life of awards outstanding as at 12/31/2022 (in years) | | 0.2 | | 2.3 | | 0.8 |
1 For these awards, the fair value is calculated by subtracting expected future dividends, if any, until maturity of the respective award from the prevailing share price as at the measurement date. Fair Value and Parameters Used at Year End 2021 | | | | | | | €, unless otherwise stated | | LTI 2016 Plan | | LTI 2020 | | Move | | | (2018-2019 | | (2020 -2021 | | (2018-2021 | | | Tranches) | | Tranches) | | Tranches) | Weighted average fair value as at 12/31/2021 | | 64.16 | | 118.73 | | 122.88 | Information how fair value was measured at measurement date | | | | | | | Valuation model used | | Monte Carlo | | Monte Carlo | | Other1 | Share price | | 124.90 | | 124.90 | | 124.90 | Risk-free interest rate, depending on maturity (in %) | | -0.72 to -0.12 | | NA | | -0.72 to -0.32 | Expected volatility (in %) | | 21 | | 30 to 32 | | NA | Expected dividend yield (in %) | | 1.52 | | NA | | 1.52 | Weighted average remaining life of awards outstanding as at 12/31/2021 (in years) | | 0.7 | | 2.8 | | 1.1 |
1 For these awards, the fair value is calculated by subtracting expected future dividends, if any, until maturity of the respective award from the prevailing share price as at the measurement date.
|
Summary of Changes in Numbers of Outstanding Awards |
| | | | | | | Thousands, unless otherwise stated | | LTI 2016 Plan | | LTI 2020 | | Move | | | (2018–2019 | | (2020–2022 | | (2018–2022 | | | Tranches) | | Tranches) | | Tranches) | 12/31/2020 | | 767 | | 172 | | 16,993 | Granted | | 0 | | 238 | | 12,204 | Adjustment based upon KPI target achievement | | -150 | | NA | | 153 | Exercised | | -92 | | 0 | | -8,092 | Exchanged | | NA | | NA | | -1,309 | Forfeited | | -57 | | -70 | | -1,165 | 12/31/2021 | | 469 | | 340 | | 18,783 | Granted2 | | 0 | | 206 | | 2,997 | Adjustment based upon KPI target achievement | | -122 | | NA | | -36 | Exercised | | -77 | | 0 | | -8,869 | Forfeited | | 0 | | 0 | | -1,016 | 12/31/2022 | | 270 | | 546 | | 11,859 | | | | | | | | Total carrying amount (in € millions) of liabilities as at | | | | | | | 12/31/2021 | | 28 | | 15 | | 1,260 | 12/31/2022 | | 18 | | 23 | | 752 | | | | | | | | Total intrinsic value of vested awards (in € millions) as at | | | | | | | 12/31/2021 | | 38 | | 4 | | 0 | 12/31/2022 | | 22 | | 3 | | 0 | | | | | | | | Weighted average share price (in €) for awards exercised in | | | | | | | 2021 | | 106.68 | | NA | | 107.69 | 2022 | | 106.59 | | NA | | 97.35 | | | | | | | | Total expense (in € millions) recognized in | | | | | | | 2020 | | -9 | | 6 | | 760 | 2021 | | -11 | | 9 | | 1,139 | 2022 | | -2 | | 8 | | 346 |
2 We have changed the classification of some share units granted under the Move plan with the initial intention to settle in shares from equity-settled to cash-settled because a cash outflow became probable. Share units with switched classification are considered in the number of granted share units.
|
Summary of Share Based Payment Liabilities As Part of Other Non-Financial Liabilities |
| | | | | | | | | | | | | € millions | | 2022 | | 2021 | | | Current | | Non-Current | | Total | | Current | | Non-Current | | Total | Share-based payment liabilities | | 524 | | 279 | | 803 | | 839 | | 462 | | 1,302 | / Other non-financial liabilities | | 4,818 | | 705 | | 5,523 | | 5,203 | | 860 | | 6,063 | Share-based payment liabilities as % of / Other non-financial liabilities | | 11 | | 40 | | 15 | | 16 | | 54 | | 21 |
|
Equity-Settled Share-Based Payments |
|
SHARE-BASED PAYMENTS |
|
Summary of Fair Value and Parameters Used at Grant Date |
| | | | | €, unless otherwise stated | | Move | | Qualtrics Plan | | | (2022 Tranches) | | | Weighted average fair value as at grant date | | 93.80 | | US$ 20.69 | Information how fair value was measured at grant date | | | | | Valuation model used | | Other3 | | Other3 | Weighted average share price | | 97.61 | | US$ 20.69 | Weighted average expected dividend yield (in %) | | 2.43 | | 0 | Weighted average initial life at grant date (in years) | | 1.6 | | 2.1 | Weighted average remaining life of awards outstanding as at 12/31/2022 (in years) | | 1.2 | | 2.4 |
|
Summary of Changes in Numbers of Outstanding Awards |
| | | | | | | | | | | | Move | | Qualtrics Plan | Thousands, unless otherwise stated | | (2022 Tranches) | | | 12/31/2020 | | NA | | 0 | Exchanged | | NA | | 12,872 | Granted | | NA | | 80,856 | Exercised | | NA | | -7,467 | Forfeited | | NA | | -2,241 | 12/31/2021 | | NA | | 84,018 | Granted4 | | 15,371 | | 35,490 | Adjustment based upon KPI target achievement | | -139 | | 0 | Exercised | | -3,258 | | -34,320 | Forfeited | | -470 | | -7,048 | 12/31/2022 | | 11,504 | | 78,140 |
|
Schedule of Number of Shares Purchased |
Numbers of Shares Purchased | | | | | | | Millions | | 2022 | | 2021 | | 2020 | Own | | 9.2 | | 5.7 | | 5.5 |
|